Biological Aging Acceleration in Major Depressive Disorder: A Multi‐Omics Analysis
Aging Cell · 2026
DOI: 10.1111/acel.70310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Breno Satler Diniz und 10 weiteren Autor:innen. Beteiligte Einrichtung: UConn Center on Aging, University of Connecticut Health Center, Farmington, Connecticut, USA. Hauptthemen laut MEDLINE: Aging, Major Depressive Disorder, Proteomics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Data Research UK, Academy of Finland, Office for National Statistics.
Abstract (Originalsprache)
Major depressive disorder (MDD) is linked to a higher risk of premature aging, but the mechanisms underlying this association remain unclear. Using data from two population cohorts (UK Biobank and Finnish Twin Cohort), we evaluate the relationship between systemic and organ‐specific proteomic and epigenetic aging acceleration and MDD. A lifetime history of MDD was associated with accelerated proteomic aging at both systemic and organ‐specific levels—including the brain—in both cohorts, with stronger associations than those observed with systemic epigenetic aging. Systemic and brain‐specific proteomic aging acceleration were linked to higher risks of incident MDD and a greater risk of Alzheimer's disease, related dementia, and mortality among individuals with MDD in the UK Biobank. Evidence of depressive episode remission attenuated the association between MDD and systemic and brain‐specific proteomic aging acceleration. Finally, Mendelian randomization analyses revealed a causal effect of MDD on systemic and brain‐specific proteomic aging acceleration. Our results suggest a strong bidirectional association between MDD and biological aging acceleration. Biological aging acceleration, assessed by proteomic systemic and organ‐specific clocks, can serve as a novel therapeutic target for treating MDD and for mitigating the long‐term risks of adverse health outcomes associated with this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UConn Center on Aging, University of Connecticut Health Center, Farmington, Connecticut, USA.
- Department of Psychiatry, University of Connecticut Health Center, Farmington, Connecticut, USA.
- Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland.
- Department of Psychiatry, Washington University in St Louis, St Louis, Missouri, USA.
- Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, St Paul, Minnesota, USA.
- Department of Public Health Sciences, University of Connecticut Health Center, Farmington, Connecticut, USA.
ORCID-Profile: Gabin Drouard, George A Kuchel
Förderung
- Health Data Research UK
- Academy of Finland
- Office for National Statistics
- UK Research and Innovation
- NIA NIH HHS
- National Institute on Aging
- Research Council of Finland
Zitieren
APA
Diniz, B. S., Zhao, S., Drouard, G., Vuoksimaa, E., Ollikainen, M., Lenze, E. J., Xu, M., Fortinsky, R. H., Kuchel, G. A., Kaprio, J., & Kuo, C. L. (2026). Biological Aging Acceleration in Major Depressive Disorder: A Multi‐Omics Analysis. Aging Cell. https://doi.org/10.1111/acel.70310
Vancouver
Diniz BS, Zhao S, Drouard G, Vuoksimaa E, Ollikainen M, Lenze EJ, et al. Biological Aging Acceleration in Major Depressive Disorder: A Multi‐Omics Analysis. Aging Cell. 2026. doi:10.1111/acel.70310
BibTeX
@article{Diniz2026,
author = {Diniz, Breno Satler and Zhao, Shangshu and Drouard, Gabin and Vuoksimaa, Eero and Ollikainen, Miina and Lenze, Eric J and Xu, Ming and Fortinsky, Richard H and Kuchel, George A and Kaprio, Jaakko and Kuo, Chia-Ling},
title = {Biological Aging Acceleration in Major Depressive Disorder: A Multi‐Omics Analysis},
journal = {Aging Cell},
year = {2026},
doi = {10.1111/acel.70310}
}
EUVIMED